Skip to Main Content

Paper Details

Performance of <sup>18</sup>F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
10
2020
Author NameAffiliation
Pedram HeidariMassachusetts General Hospital, Harvard Medical School
Pedram HeidariMartinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School
Mark VangelMassachusetts General Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2